Sun Set For US Eye-care Push With BromSite Approval

Sun Pharma has received FDA approval for its ophthalmology NDA, BromSite (0.075% bromfenac), the first such non-steroidal anti-inflammatory drug (NSAID ) cleared by the agency to prevent pain and treat inflammation in cataract surgery patients.